Furthermore, AF has also been associated with increased atrial oxidative stress and NADPH oxidase activity.[17] Statin treatment reduces NADPH oxidase activity pro-and inflammatory markers, such as CRP as well as the incidence of AF in a mouse model.[2,18,19]. The gene discussed is CRP; the disease is atrial fibrillation.